REQUESTING THE AUDITOR TO CONDUCT AN IMPACT ASSESSMENT OF ELIMINATING COST-SHARING FOR CERTAIN DIAGNOSTIC AND SUPPLEMENTAL BREAST EXAMINATIONS.

HCR 134 is a concurrent resolution requesting the Hawaii Auditor to assess the financial and social impacts of eliminating patient copays for specific follow-up breast exams. It directs the Auditor to analyze HB 598 (which proposes banning cost-sharing for diagnostic exams for symptomatic patients and supplemental exams for high-risk patients or those diagnosed with breast cancer). The assessment must consider how this change would interact with federal laws like the Affordable Care Act and include projected costs beyond essential health benefits. The Auditor must submit findings to the Legislature by January 2026. This resolution does not change policy but prepares for potential future legislative action.